Pivotal trial of parsaclisib in B-cell malignancies
Latest Information Update: 19 Dec 2021
At a glance
- Drugs Parsaclisib (Primary)
- Indications Chronic lymphocytic leukaemia; Non-Hodgkin's lymphoma
- Focus Adverse reactions
Most Recent Events
- 19 Dec 2021 New trial record